A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal.
The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
There currently are no established screening strategies for ovarian cancer. The disease often causes no specific symptoms and is difficult to detect in the early stages when it is most responsive to treatment. Therefore, ovarian cancer is highly lethal because most women have advanced disease when they are diagnosed.
Karen Lu, MD, of The University of Texas MD Anderson Cancer Center in Houston, led a team that tested the potential of a two-stage ovarian cancer screening strategy that incorporates changes in a blood protein called CA125, which is a known tumor marker. In their 11-year study, 4051 post- menopausal women initially underwent an annual CA125 blood test. Based on a calculation called the “Risk of Ovarian Cancer Algorithm,” women were divided into three groups: those who should receive another CA125 test one year later (low risk), those who should receive a repeat CA125 in three months (intermediate risk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high risk).
An average of 5.8 percent of women were found to be of intermediate risk each year, meaning that they should receive a CA125 test in three months. The average annual referral rate to transvaginal ultrasound and review by a gynecologic oncologist was 0.9 percent. Ten women underwent surgery based on their ultrasound exams, with four having invasive ovarian cancers, two having ovarian tumors of low malignant potential, one having endometrial cancer, and three having benign ovarian tumors. This equates to a positive predictive value of 40 percent for detecting invasive ovarian cancer. The specificity of the testing strategy was 99.9 percent, meaning that only 0.1 percent of patients without cancer would be falsely identified as having the disease. Importantly, all of the ovarian cancers were early stage.
The Latest on: Ovarian cancer
- Hidden Burdens and Trying to Feel Normal: The Effects of an Ovarian Cancer Diagnosis on February 18, 2018 at 10:03 am
After a cancer diagnosis and treatment, one may question when they will actually start to feel “normal” again, whatever that may be. The Ovarian Cancer Prognosis and Lifestyle (OPAL) study set out to help women with ovarian cancer to understand just that. […]
- Fathers' Genes Could Raise Daughters' Ovarian Cancer Risk on February 17, 2018 at 4:18 am
A new gene mutation that can be passed from fathers to daughters can increase the risk of ovarian cancer, a new research suggests. For instance, if a woman's grandmother from her father's side had ovarian cancer, the woman is also susceptible to the ... […]
- Women's Paternal Grandmas May Be Tied to This Type of Cancer on February 16, 2018 at 1:17 pm
Per the BBC, fathers can pass down a gene mutation to their daughters that can raise the risk of ovarian cancer, per a study published Thursday in Plos Genetics. The 30-year study of nearly 3,500 grandmother/granddaughter pairs culled from the Familial ... […]
- Genetic mutation from father may speed onset of ovarian cancer on February 16, 2018 at 8:09 am
Feb. 16 (UPI) --A genetic mutation linked to sped up onset of ovarian and prostate cancers, and passed through the X-chromosome, has been identified by researchers. The mutation can also advance the start of ovarian cancer by six or more years, researchers ... […]
- Ovarian Cancer Risk Factors May Include Your Father’s Genes on February 16, 2018 at 7:29 am
Fathers may be partially responsible for passing on to their daughters genetic risk factors for ovarian cancer, a new study published Thursday in PLoS Genetics has shown. By looking at the patterns of cancer within families, researchers found that women ... […]
- Fathers maybe passing on ovarian cancer genes to their daughters on February 16, 2018 at 4:13 am
According to a team of researchers from the Roswell Park Cancer Institute, a new gene mutation could be responsible for ovarian cancers and this could be passed on from fathers to their daughters. The gene in question is passed via the X chromosome that ... […]
- Routine Ovarian Cancer Screenings Aren't Helping on February 14, 2018 at 2:01 pm
Feb. 13, 2018 -- Routine screening tests for ovarian cancer is not recommended for women who aren't at high risk of getting the disease and don't have symptoms, according to updated recommendations from an expert panel. The U.S. Preventive Services Task ... […]
- USPSTF Says 'No' to Ovarian Cancer Screening on February 14, 2018 at 8:12 am
Women with no symptoms of ovarian cancer should not undergo screening for the disease, according to the U.S. Preventive Services Task Force (USPSTF). An extensive review of literature and data produced "adequate evidence that screening for ovarian cancer ... […]
- Ovarian Cancer Doesn’t Begin in the Ovaries, Researchers Say on February 12, 2018 at 1:00 pm
A growing body of evidence suggests that ovarian cancer begins in the fallopian tubes and not the ovaries, giving researchers hope for developing better strategies to prevent and detect the deadly cancer. Among women with cancer, ovarian cancer is the ... […]
via Google News and Bing News